A study published in the journal 'Cancer Research' suggested that sildenafil, the active ingredient in Viagra, could slow the spread of cancer by restricting the access of cancer cells to cholesterol. Cancer cells, after breaking away from primary tumour, rely on cholesterol to survive and establish new tumours. However, sildenafil is not a proven cancer treatment.